NCT03548259 (PRP-CTS) is a NA clinical trial of Platelet-rich plasma in Carpal Tunnel Syndrome, sponsored by Cardenal Herrera University.

Who is sponsoring NCT03548259?

NCT03548259 is sponsored by Cardenal Herrera University.

What drugs are being tested in NCT03548259?

Interventions in NCT03548259: Platelet-rich plasma, Platelet-poor plasma.

What condition does NCT03548259 study?

NCT03548259 studies Carpal Tunnel Syndrome.

Is NCT03548259 still recruiting?

NCT03548259 is currently completed. Last updated 4 February 2019.

Last reviewed 2019-02-04 · How we verify

NCT03548259: PRP-CTS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Platelet-rich Plasma in the Surgery of Carpal Tunnel Syndrome: A Randomized Controlled Trial

Completed NA Last updated 4 February 2019

What this trial tests

NA trial testing Platelet-rich plasma in Carpal Tunnel Syndrome in 50 participants. Completed in 5 November 2018.

Timeline

5 June 2018

Primary endpoint
5 November 2018

5 November 2018

Quick facts

Lead sponsor	Cardenal Herrera University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	50
Start date	5 June 2018
Primary completion	5 November 2018
Estimated completion	5 November 2018
Sites	1 location across Spain

Drugs / interventions tested

Platelet-rich plasma
Platelet-poor plasma

Conditions studied

Carpal Tunnel Syndrome — all drugs for Carpal Tunnel Syndrome →

Sponsor

Cardenal Herrera University

Who can join

Adults 18 to 65, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Platelet-rich plasma (PRP) has been proved to be efficient in the non-surgical treatment of carpal tunnel syndrome (CTS). Here we propose to assess the effectiveness of PRP as co-adjuvant in surgical treatment of CTS by open carpal tunnel release. Design: Randomized Controlled Trial. Setting: Local Hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Platelet-rich plasma

Trials testing the same drug.

NCT07103551 — Evaluation of the Efficacy of Injectable Platelet-rich Plasma in Tooth Movement Acceleration With Clear Aligner · Phase 3 · not yet recruiting
NCT06372600 — Effect of Extracorporeal Shock Wave Combined With Autologous Platelet-rich Plasma Injection on Rotator Cuff Calcific Ten · NA · not yet recruiting
NCT06442319 — The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction. · NA · recruiting
NCT05329116 — Efficacy of Mesotherapy Added to Intra-articular Platelet-rich Plasma (PRP) in Patients With Knee Osteoarthritis · NA · unknown
NCT05214924 — Effectiveness of iPRF Injections in Temporomandibular Joints Degeneration Management · Phase 2, PHASE3 · enrolling by invitation

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

NCT07312123 — A Study to See Whether Taking a Mix of Vitamins Can Help Adults Recover Better After Surgery for Carpal Tunnel Syndrome · NA · recruiting
NCT07334964 — Ultrasound-Guided Carpal Tunnel Infiltration: Comparison Between the Manual Method and a Robot-Assisted Method · NA · recruiting
NCT07414069 — High-Intensity Laser Therapy in Carpal Tunnel Syndrome: Clinical, Sonographic, and Electrophysiological Outcomes · NA · recruiting
NCT07114913 — Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome · recruiting
NCT06905769 — Effects of Aquatic Therapy Versus Neuro-dynamic Technique for the Treatment of Carpal Tunnel Syndrome Patient · NA · active not recruiting

Other Cardenal Herrera University trials

Trials by the same sponsor.

NCT07471269 — Online Pain Neuroscience Education For Fear Of Childbirth. · NA · recruiting
NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
NCT07499856 — Intradialytic Exercise Program Supported by Audiovisual Media Combined With Mindfulness · NA · enrolling by invitation
NCT07275112 — Cross-cultural an Reliability and Validity Evaluation of TENDINS-A in Spain · completed
NCT07133581 — Design and Validation of FEXO: A Playful Exercise Program for Institutionalized Frail Older Adults · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03548259 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cardenal Herrera University
Last refreshed: 4 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03548259.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing